Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
iShares iBonds Dec 2032 Term Treasury ETF
IBTM
$556M
| $19.1M | ﹤0.01% |
826,446
-1,998
| -0.2% | -$46.3K |
|
2977
CRA International
CRAI
$1.18B
| $19.1M | ﹤0.01% |
94,998
+17,601
| +23% | +$3.32M |
|
2978
John Wiley & Sons Class A
WLY
$2.71B
| $19M | ﹤0.01% |
621,784
-746,391
| -55% | -$26.3M |
|
2979
Nomad Foods
NOMD
$1.72B
| $19M | ﹤0.01% |
1,520,507
+537,954
| +55% | +$6.57M |
|
2980
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$733M
| $19M | ﹤0.01% |
739,858
+90,188
| +14% | +$2.37M |
|
|
NCV
2981
Virtus Convertible & Income Fund
NCV
$376M
| $19M | ﹤0.01% |
1,254,551
-118,910
| -9% | -$1.82M |
|
2982
PennyMac Financial
PFSI
$4.47B
| $19M | ﹤0.01% |
144,092
+28,819
| +25% | +$3.67M |
|
2983
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$902M
| $19M | ﹤0.01% |
1,882,329
+598,615
| +47% | +$6.06M |
|
2984
iShares Cybersecurity and Tech ETF
IHAK
$1.01B
| $19M | ﹤0.01% |
394,121
-23,005
| -6% | -$1.16M |
|
2985
Arlo Technologies
ARLO
$1.54B
| $18.9M | ﹤0.01% |
1,350,487
-23,975
| -2% | -$377K |
|
2986
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.69B
| $18.9M | ﹤0.01% |
335,577
+11,496
| +4% | +$646K |
|
|
ARI
2987
Apollo Commercial Real Estate
ARI
$880M
| $18.9M | ﹤0.01% |
1,950,734
+350,933
| +22% | +$3.51M |
|
2988
Global X Lithium & Battery Tech ETF
LIT
$1.46B
| $18.9M | ﹤0.01% |
291,026
+21,985
| +8% | +$1.35M |
|
2989
Liberty All-Star Equity Fund
USA
$1.79B
| $18.9M | ﹤0.01% |
3,005,226
-404,297
| -12% | -$2.52M |
|
2990
NRC Health Common Stock
NRC
$506M
| $18.8M | ﹤0.01% |
1,003,709
+146,074
| +17% | +$2.2M |
|
2991
ICF International
ICFI
$1.52B
| $18.8M | ﹤0.01% |
220,635
-58,188
| -21% | -$4.94M |
|
2992
iShares MSCI Poland ETF
EPOL
$674M
| $18.8M | ﹤0.01% |
534,227
+31,480
| +6% | +$1.06M |
|
2993
Ramaco Resources Class A
METC
$634M
| $18.8M | ﹤0.01% |
1,041,733
-37,790
| -4% | -$993K |
|
|
KEEL
2994
Keel Infrastructure Corp
KEEL
$2.26B
| $18.7M | ﹤0.01% |
7,974,858
+6,123,825
| +331% | +$21M |
|
|
MYD
2995
DELISTED
BlackRock MuniYield Fund
MYD
| $18.7M | ﹤0.01% |
1,784,936
+284,794
| +19% | +$2.99M |
|
2996
Sharplink Inc
SBET
$1.35B
| $18.7M | ﹤0.01% |
2,091,194
-80,252
| -4% | -$980K |
|
2997
La-Z-Boy
LZB
$1.66B
| $18.7M | ﹤0.01% |
501,516
+41,241
| +9% | +$1.44M |
|
2998
NewAmsterdam Pharma
NAMS
$3.34B
| $18.7M | ﹤0.01% |
532,803
-964,676
| -64% | -$35.1M |
|
2999
REX American Resources
REX
$1.42B
| $18.7M | ﹤0.01% |
577,406
+33,744
| +6% | +$1.1M |
|
3000
Adaptive Biotechnologies
ADPT
$3.61B
| $18.7M | ﹤0.01% |
1,149,082
+77,012
| +7% | +$1.26M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.